5-HT Receptor Inhibitors

5-HT₁ Receptor

5-HT₂ Receptor

5-HT₃ Receptor

5-HT₅ Receptor

5-HT₆ Receptor

5-HT₇ Receptor

5-HT Receptor

5-HT₄ Receptor

5-HT Receptor Inhibitors, Agonists, Antagonists & Modulators

Product Name	5-HT₁ Receptor	5-HT₂ Receptor	5-HT₃ Receptor	5-HT₅ Receptor	5-HT₆ Receptor	5-HT₇ Receptor	5-HT Receptor	5-HT₄ Receptor	Purity
Puerarin		5-HT_2C Receptor							99.20%
SCH-23390 hydrochloride		5-HT_2C Receptor, Ki: 9.3 nM							99.31%
GTS-21 dihydrochloride			5-HT_3A Receptor, IC₅₀: 3.1 μM						99.78%
SB-269970 hydrochloride						5-HT₇ Receptor, pKi: 8.3			98.77%
NLX-204 hydrochloride	5-HT_1A Receptor, pKi: 10.19								99.81%
Eplivanserin hemifumarate		5-HT_2A Receptor, IC₅₀: 5.8 nM 5-HT_2C Receptor, IC₅₀: 120 nM							98.07%
Risperidone		5-HT_2A Receptor, Ki: 4.8 nM							98.01%
Ketanserin		5-HT₂ Receptor							≥98.0%
Thioridazine hydrochloride							serotonin		99.93%
Aripiprazole	5-HT_1A Receptor, Ki: 4.2 nM								99.93%
Amitriptyline hydrochloride	5-HT_1A Receptor, IC₅₀: 450 nM 5-HT_1B Receptor, IC₅₀: 40 nM	5-HT_2A Receptor, IC₅₀: 4 nM 5-HT_2B Receptor, IC₅₀: 40 nM 5-HT_2C Receptor, IC₅₀: 6 nM							99.56%
Pimavanserin		5-HT_2A Receptor, pIC₅₀: 8.7							99.78%
Brexpiprazole	5-HT_1A Receptor, Ki: 0.12 nM	5-HT_2A Receptor, Ki: 0.47 nM							99.40%
Cisapride								5-HT₄ Receptor, EC₅₀: 0.14 μM	99.72%
Quetiapine	5-HT_1A Receptor, pKi: 5.74 5-HT_1A Receptor, pEC₅₀: 4.77	5-HT_2A Receptor, pKi: 7.54 5-HT_2C Receptor, pKi: 5.55							99.96%
8-OH-DPAT	5-HT_1A Receptor, pIC₅₀: 8.19					5-HT₇ Receptor, Ki: 466 nM			≥98.0%
Lurasidone	5-HT_1A Receptor, IC₅₀: 6.75 nM					5-HT₇ Receptor, IC₅₀: 0.495 nM			99.90%
Lumateperone tosylate		5-HT_2A Receptor, Ki: 0.54 nM							99.42%
Methiothepin mesylate	5-HT_1A Receptor, pKd: 7.10 5-HT_1B Receptor, pKd: 7.28 5-HT_1C Receptor, pKd: 7.56 5-HT_1D Receptor, pKd: 6.99	5-HT_2A Receptor, pKi: 8.50 5-HT_2B Receptor, pKi: 8.68 5-HT_2C Receptor, pKi: 8.35		5-HT_5A Receptor, pKd: 7.0 5-HT_5B Receptor, pKd: 7.8	5-HT₆ Receptor, pKd: 8.74	5-HT₇ Receptor, pKd: 8.99			≥98.0%
SB-224289 hydrochloride	5-HT_1B Receptor								≥99.0%
Pindolol	5-HT_1A Receptor								99.91%
Pimavanserin tartrate		5-HT_2A Receptor, pIC₅₀: 8.73 5-HT_2A Receptor, pKi: 9.3							99.75%
Perphenazine		5-HT_2A Receptor, Ki: 5.6 nM							99.72%
Volinanserin		5-HT₂ Receptor, Ki: 0.36 nM							98.33%
Sertindole		5-HT_2A Receptor 5-HT_2C Receptor							99.76%
Ketanserin tartrate		5-HT₂ Receptor							99.99%
Vortioxetine hydrobromide			5-HT_3A Receptor, Ki: 3.7 nM			5-HT₇ Receptor, Ki: 19 nM			99.94%
Ziprasidone	Rat 5-HT_1A Receptor, Ki: 3.4 nM human 5-HT_1A Receptor, Ki: 2.5 nM	Rat 5-HT_2A, Ki: 0.42 nM							98.28%
Tegaserod maleate		5-HT_2B Receptor (Antagonist)						5-HT₄ Receptor (Agonist)	99.75%
Piboserod								5-HT₄ Receptor	99.12%
Ondansetron			5-HT₃ Receptor						99.41%
SB 242084		5-HT_2C Receptor, pKi: 9.0							99.84%
Paliperidone		5-HT_2A Receptor							99.87%
Ritanserin		5-HT₂ Receptor, IC₅₀: 0.9 nM							≥99.0%
Cyproheptadine hydrochloride		5-HT₂ Receptor							99.98%
Vortioxetine			5-HT_3A Receptor, Ki: 3.7 nM			Human 5-HT₇ Receptor , Ki: 19 nM			99.52%
Nefazodone hydrochloride		5-HT_2A Receptor, Ki: 5.8 nM							99.02%
Agomelatine		5-HT_2C Receptor, pKi: 6.4 (native porcine) 5-HT_2C Receptor, pKi: 6.2 (human)							98.77%
LP-211	5-HT_1A Receptor, Ki: 188 nM					5-HT₇ Receptor, Ki: 0.58 nM			99.61%
(Z)-Thiothixene							serotonin		99.76%
SKF-83566		5-HT₂ Receptor, Ki: 11 nM							99.86%
SEP-363856 hydrochloride	5-HT_1A Receptor, EC₅₀: 2.3 μM 5-HT_1B Receptor, EC₅₀: 15.6 μM 5-HT_1D Receptor, EC₅₀: 0.262 μM	5-HT_2A Receptor, EC₅₀: >10 μM 5-HT_2C Receptor, EC₅₀: 30 μM				5-HT₇ Receptor, EC₅₀: 6.7 μM			99.78%
Alprenolol hydrochloride	5-HT_1A Receptor								99.78%
Vabicaserin hydrochloride		5-HT_2C Receptor, EC₅₀: 8 nM							≥95.0%
Vilazodone	5-HT_1A Receptor								99.91%
2-Methyl-5-HT			5-HT₃ Receptor						98.09%
Cariprazine hydrochloride	5-HT_1A Receptor, Ki: 2.6 nM								99.89%
Prucalopride								5-HT_4A Receptor, pKi: 8.6 5-HT_4B Receptor, pKi: 8.1	99.89%
Lurasidone Hydrochloride	5-HT_1A Receptor, IC₅₀: 6.75 nM					5-HT₇ Receptor, IC₅₀: 0.495 nM			99.87%
Palonosetron hydrochloride			5-HT₃ Receptor						99.96%
Asenapine maleate		5-HT_2A Receptor, Ki: 0.06 nM 5-HT_2C Receptor, Ki: 0.03 nM				5-HT₇ Receptor, Ki: 0.13 nM			99.95%
Xanthotoxol							serotonin		99.58%
Alosetron Hydrochloride			5-HT₃ Receptor						99.79%
RU 24969	5-HT_1B Receptor, Ki: 0.38 nM 5-HT_1A Receptor, Ki: 2.5 nM								99.97%
Mosapride citrate								5-HT₄ Receptor	99.80%
Alprenolol	5-HT_1A Receptor								99.87%
Flibanserin	5-HT_1A Receptor, Ki: 1 nM	5-HT_2A Receptor, Ki: 49 nM							99.10%
Nuciferine	5-HT_1A Receptor, EC₅₀: 3.2 μM	5-HT_2C Receptor, IC₅₀: 131 nM 5-HT_2A Receptor, IC₅₀: 478 nM 5-HT_2B Receptor, IC₅₀: 1 μM			5-HT₆ Receptor, EC₅₀: 700 nM	5-HT₇ Receptor, IC₅₀: 150 nM			99.66%
Perospirone	5-HT_1A Receptor, Ki: 2.9 nM 5-HT₁ Receptor, Ki: 18 nM	5-HT_2A Receptor, Ki: 0.6 nM							99.51%
Rotigotine	5-HT_1A Receptor, Ki: 30 nM					5-HT₇ Receptor, Ki: 86 nM			99.98%
Pizotifen		5-HT_2A Receptor							99.73%
Tandospirone	5-HT_1A Receptor, Ki: 27 nM								99.41%
Eletriptan hydrobromide	5-HT_1B Receptor, Ki: 0.92 nM 5-HT_1D Receptor, Ki: 3.14 nM								98.13%
Cariprazine	5-HT_1A Receptor, Ki: 2.6 nM								99.35%
Gamma-Mangostin		5-HT_2A Receptor							99.90%
Sumatriptan succinate	5-HT_1D Receptor								99.73%
Asenapine	5-HT_1A Receptor, pKi: 8.6 5-HT_1B Receptor, pKi: 8.4	5-HT_2A Receptor, pKi: 10.2 5-HT_2C Receptor, pKi: 10.5 5-HT_2B Receptor, pKi: 9.8		5-HT₅ Receptor, pKi: 8.8	5-HT₆ Receptor, pKi: 9.6	5-HT₇ Receptor, pKi: 9.9			98.81%
Azasetron hydrochloride			5-HT₃ Receptor, IC₅₀: 0.33 nM						99.75%
Granisetron Hydrochloride			5-HT₃ Receptor, IC₅₀: 17 μM						99.86%
Mirtazapine		5-HT₂ Receptor, pKi: 8.05	5-HT₃ Receptor, pKi: 8.1						99.97%
SB 243213	human 5-HT_1A Receptor, pKi: <5.3 human 5-HT_1B Receptor, pKi: 5.5 human 5-HT_1D Receptor, pKi: 6.32 human 5-HT_1E Receptor, pKi: <5.4 human 5-HT_1F Receptor, pKi: 5.35	Human 5-HT_2C Receptor, pKi: 9.37 Human 5-HT_2A Receptor, pKi: 7.01 human 5-HT_2B Receptor, pKi: 7.2			Human 5-HT₆ Receptor, pKi: 6.5	Human 5-HT₇ Receptor , pKi: 5.64			98.62%
R 59-022							serotonin		≥99.0%
Sarpogrelate hydrochloride		5-HT_2A Receptor, pKi: 8.52 5-HT_2B Receptor, pKi: 6.57 5-HT_2C Receptor, pKi: 7.43							≥98.0%
Idalopirdine Hydrochloride					5-HT₆ Receptor, Ki: 0.83 nM				99.83%
Rotigotine Hydrochloride	5-HT_1A Receptor, Ki: 30 nM					5-HT₇ Receptor, Ki: 86 nM			≥95.0%
Spiperone hydrochloride	5-HT_1A Receptor, Ki: 49 nM	5-HT_2A Receptor, Ki: 1 nM							≥99.0%
Cinanserin hydrochloride		5-HT₂ Receptor, Ki: 41 nM							99.74%
Piromelatine	5-HT_1A Receptor (Agonist) 5-HT_1D Receptor (Agonist)	5-HT_2B Receptor (Antagonist)							99.21%
Vilazodone Hydrochloride	5-HT_1A Receptor								≥99.0%
LY310762	5-HT_1D Receptor, Ki: 249 nM								99.84%
Blonanserin		5-HT_2A Receptor, Ki: 0.812 nM 5-HT_2C Receptor, Ki: 26.4 nM			5-HT₆ Receptor, Ki: 11.7 nM				98.73%
Intepirdine					5-HT₆ Receptor, pKi: 9.63				98.92%
BRL 54443	5-HT_1E Receptor, Ki: 1.1 nM 5-HT_1F Receptor, Ki: 0.7 nM 5-HT_1A Receptor, Ki: 63 nM 5-HT_1B Receptor, Ki: 126 nM 5-HT_1D Receptor, Ki: 63 nM	5-HT_2A Receptor, Ki: 1259 nM 5-HT_2B Receptor, Ki: 100 nM 5-HT_2C Receptor, Ki: 316 nM			5-HT₆ Receptor, Ki: >10,000 nM	5-HT₇ Receptor, Ki: >10,000 nM			99.39%
Tropisetron Hydrochloride			5-HT₃ Receptor, IC₅₀: 70.1 nM						99.95%
Setiptiline maleate		5-HT_2A Receptor 5-HT_2C Receptor	5-HT₃ Receptor						98.18%
BRL-15572 dihydrochloride	5-HT_1D Receptor								99.78%
Nelotanserin		5-HT_2A Receptor, IC₅₀: 1.7 nM 5-HT_2C Receptor, IC₅₀: 79 nM 5-HT_2B Receptor, IC₅₀: 791 nM							99.79%
SB 258719						5-HT₇ Receptor, pKi: 7.5			≥99.0%
RS-127445 hydrochloride		5-HT_2A Receptor, pKi: 6.3 5-HT_2C Receptor, pKi: 6.4 5-HT_2B Receptor, pKi: 9.5	5-HT₃ Receptor, pKi: <6	5-HT₅ Receptor, pKi: <6	5-HT₆ Receptor, pKi: <6				99.58%
SB 242084 dihydrochloride		5-HT_2C Receptor, pKi: 9.0							98.33%
Adoprazine	5-HT_1A Receptor, pEC₅₀: 9 5-HT_1A Receptor, pKi: 9.1					5-HT₇ Receptor, pKi: 7.2			98.10%
Eltoprazine hydrochloride	5-HT_1A Receptor 5-HT_1B Receptor	5-HT_2C Receptor							99.85%
Metergoline		5-HT_2A Receptor, pKi: 8.64 5-HT_2B Receptor, pKi: 8.75 5-HT_2C Receptor, pKi: 8.75				Human 5-HT₇ Receptor , Ki: 16 nM			99.74%
Ondansetron hydrochloride dihydrate			5-HT₃ Receptor						99.03%
Trimipramine maleate		5-HT₂ Receptor, pKi: 8.10							99.84%
Iloperidone	Rat 5-HT_1A Receptor, Ki: 168 nM	Rat 5-HT₂ Receptor, Ki: 3.1 nM Human 5-HT_2A Receptor, Ki: 5.6 nM Human 5-HT_2C Receptor, Ki: 42.8 nM			Rat 5-HT₆ Receptor, Ki: 42.7 μM	Rat 5-HT₇ Receptor, Ki: 21.6 nM			99.64%
Roluperidone		5-HT_2A Receptor, Ki: 7.53 nM							99.51%
Syk Inhibitor II							serotonin, IC₅₀: 460 nM		98.05%
SB-277011 hydrochloride	5-HT_1D Receptor 5-HT_1B Receptor								98.22%
Pipamperone	5-HT₁ Receptor, pKi: 5.7	5-HT_2A Receptor, pKi: 8.2 5-HT_2C Receptor, pKi: 6.9							99.89%
SB-399885 hydrochloride					5-HT₆ Receptor				99.54%
Spiramide	5-HT_1A Receptor, Ki: 50 nM 5-HT_1C Receptor, Ki: 4300 nM	5-HT₂ Receptor, Ki: 2 nM							98.81%
Arotinolol		5-HT_2A Receptor							98.23%
Asenapine hydrochloride		5-HT_2A Receptor, Ki: 0.06 nM 5-HT_2C Receptor, Ki: 0.03 nM				5-HT₇ Receptor, Ki: 0.13 nM			98.76%
Dolasetron			5-HT₃ Receptor						≥98.0%
Quetiapine hemifumarate	5-HT_1A Receptor, pKi: 5.74 5-HT_1A Receptor, pEC₅₀: 4.77	5-HT_2A Receptor, pKi: 7.54 5-HT_2C Receptor, pKi: 5.55							98.24%
Ansofaxine hydrochloride							serotonin, IC₅₀: 723 nM		99.85%
Pumosetrag Hydrochloride			5-HT₃ Receptor						99.77%
GSK163090	5-HT_1A Receptor, pKi: 9.4 5-HT_1B Receptor, pKi: 8.5 5-HT_1D Receptor, pKi: 9.7	5-HT_2A Receptor, pKi: 6 5-HT_2B Receptor, pKi: 6.3 5-HT_2C Receptor, pKi: 5.8			Human 5-HT₆ Receptor, pKi: <5.3	Human 5-HT₇ Receptor , pKi: 6.8			99.95%
JNJ-18038683						Rat 5-HT₇ Receptor, pKi: 8.19 (in HEK293 cells ) Human 5-HT₇ Receptor , pKi: 8.20 (in HEK293 cells )			99.21%
OPC-14523 hydrochloride	5-HT_1A Receptor, IC₅₀: 2.3 nM								99.90%
Fananserin		5-HT₂ Receptor, Ki: 0.37 nM							99.83%
Pimethixene maleate	5-HT_1A Receptor, pKi: 7.63	5-HT_2A Receptor, pKi: 10.22 5-HT_2B Receptor, pKi: 10.44 5-HT_2C Receptor, pKi: 8.42							≥98.0%
LY 344864	5-HT_1F Receptor, Ki: 6 nM								99.16%
Talipexole dihydrochloride			5-HT₃ Receptor						99.88%
PRX-08066		5-HT_2B Receptor, IC₅₀: 3.4 nM							97.04%
Befiradol hydrochloride	5-HT_1A Receptor								99.74%
Rotundine	5-HT_1A Receptor, IC₅₀: 370 nM								99.88%
Eptapirone	5-HT_1A Receptor								99.91%
Phenylbiguanide			5-HT₃ Receptor, EC₅₀: 3 μM						≥98.0%
Rizatriptan benzoate	5-HT₁ Receptor								99.93%
Paliperidone palmitate		5-HT_2A Receptor							98.16%
p-MPPI hydrochloride	5-HT_1A Receptor								99.19%
SB-200646A		5-HT_2B Receptor, pKi: 7.5 5-HT_2C Receptor, pKi: 6.9 5-HT_2A Receptor, pKi: 5.2							99.47%
Almotriptan malate	5-HT_1B Receptor 5-HT_1D Receptor								99.91%
SB 271046 Hydrochloride	5-HT_1D Receptor, pKi: 6.55 5-HT_1A Receptor, pKi: 6.35 5-HT_1B Receptor, pKi: 6.05 5-HT_1F Receptor, pKi: 5.95 5-HT_1E Receptor, pKi: <4.99	5-HT_2A Receptor, pKi: 5.62 5-HT_2B Receptor, pKi: 5.41 Human 5-HT_2C Receptor, pKi: 5.73			5-HT₆ Receptor, pKi: 8.92-9.02	5-HT₇ Receptor, pKi: 5.39		5-HT₄ Receptor, pKi: 5.27	98.64%
Alverine citrate	5-HT_1A Receptor, IC₅₀: 101 nM								99.43%
Ziprasidone hydrochloride monohydrate	Rat 5-HT_1A Receptor, : 3.4 nM human 5-HT_1A Receptor, : 2.5 nM	Rat 5-HT_2A, : 0.42 nM							99.83%
PF-04995274								5-HT₄ Receptor	99.42%
Donitriptan	5-HT_1B Receptor, pKi: 9.4 5-HT_1D Receptor, pKi: 9.3								98.12%
Geissoschizine methyl ether	5-HT_1A Receptor								≥98.0%
Urapidil	5-HT_1A Receptor								99.94%
Flesinoxan	5-HT_1A Receptor, EC₅₀: 24 nM								99.07%
F13714 fumarate	5-HT_1A Receptor								98.65%
Bemesetron			5-HT₃ Receptor, IC₅₀: 0.33 nM						≥99.0%
SB-616234-A	5-HT_1B Receptor								98.14%
Oxatomide							serotonin		99.47%
(Rac)-Rotigotine hydrochloride	5-HT_1A Receptor, Ki: 30 nM	5-HT_2B Receptor, Ki: 27 nM							98.66%
Agomelatine hydrochloride		5-HT_2C Receptor, pKi: 6.4 (native porcine) 5-HT_2C Receptor, pKi: 6.2 (human)							99.55%
Ramosetron Hydrochloride			5-HT₃ Receptor						99.91%
Tianeptine							serotonin		99.24%
Cyproheptadine hydrochloride sesquihydrate		5-HT₂ Receptor							99.00%
Prucalopride succinate								5-HT_4A Receptor, pKi: 8.6 5-HT_4B Receptor, pKi: 8.1	99.83%
LY334370	5-HT_1F Receptor, Ki: 1.6 nM								99.80%
Tropisetron			5-HT₃ Receptor, IC₅₀: 70.1 nM						≥98.0%
NAN-190 hydrobromide	5-HT₁ Receptor								99.02%
Xaliproden hydrochloride	5-HT_1A Receptor, IC₅₀: 3 nM								99.05%
WAY-181187					5-HT₆ Receptor, Ki: 2.2 nM 5-HT₆ Receptor, EC₅₀: 6.6 nM				98.05%
Ocaperidone	5-HT_1A Receptor, pEC₅₀: 7.6 (h5-HT_1A) 5-HT_1A Receptor, pKi: 8.08 (h5-HT_1A)	5-HT₂ Receptor, Ki: 0.14 nM							99.63%
Cyamemazine		5-HT_2A Receptor, Ki: 1.5 nM 5-HT_2C Receptor, Ki: 12 nM	5-HT₃ Receptor, Ki: 75 nM						≥99.0%
Flumexadol		5-HT_2C Receptor, Ki: 25 nM							98.87%
Iferanserin		5-HT_2A Receptor							99.74%
Flopropione	5-HT_1A Receptor								98.93%
Tedatioxetine hydrobromide		5-HT_2A Receptor 5-HT_2C Receptor	5-HT₃ Receptor						99.98%
Tianeptine sodium salt							serotonin		99.82%
Pardoprunox hydrochloride	5-HT_1A Receptor, pEC₅₀: 6.3								98.24%
Isocorynoxeine		5-HT_2A Receptor, IC₅₀: 72.4 μM							99.97%
Lidanserin		5-HT_2A Receptor							≥98.0%
AVN-492					5-HT₆ Receptor, Ki: 91 pM				99.49%
Peptide 401							serotonin
SKF-83566 hydrobromide		5-HT₂ Receptor, Ki: 11 nM
SB 243213 dihydrochloride	human 5-HT_1A Receptor, pKi: <5.3 human 5-HT_1B Receptor, pKi: 5.5 human 5-HT_1D Receptor, pKi: 6.32 human 5-HT_1E Receptor, pKi: <5.4 human 5-HT_1F Receptor, pKi: 5.35	Human 5-HT_2C Receptor, pKi: 9.37 Human 5-HT_2A Receptor, pKi: 7.01 human 5-HT_2B Receptor, pKi: 7.2			Human 5-HT₆ Receptor, pKi: 6.5	Human 5-HT₇ Receptor , pKi: 5.64			≥99.0%
GR 125743	human 5-HT_1B Receptor, pKi: 8.85 human 5-HT_1D Receptor, pKi: 8.31								99.78%
cis-Urocanic acid		5-HT_2A Receptor							99.92%
Fabesetron			5-HT₃ Receptor					5-HT₄ Receptor	95.72%
Temanogrel		5-HT_2A Receptor, Ki: 4.9 nM							98.94%
Strictosidinic acid							5-HT Receptor
EMD 56551	5-HT_1A Receptor
5-HT1A modulator 1		5-HT_2A Receptor, IC₅₀: 500 nM 5-HT_2C Receptor, IC₅₀: 4000 nM							97.12%
Velusetrag								5-HT₄ Receptor, pKi: 7.7	99.64%
SB 243213 hydrochloride	human 5-HT_1A Receptor, pKi: <5.3 human 5-HT_1B Receptor, pKi: 5.5 human 5-HT_1D Receptor, pKi: 6.32 human 5-HT_1E Receptor, pKi: <5.4 human 5-HT_1F Receptor, pKi: 5.35	Human 5-HT_2C Receptor, pKi: 9.37 Human 5-HT_2A Receptor, pKi: 7.01 human 5-HT_2B Receptor, pKi: 7.2			Human 5-HT₆ Receptor, pKi: 6.5	Human 5-HT₇ Receptor , pKi: 5.64
Hypidone hydrochloride	5-HT_1A Receptor								99.77%
OPC-14523 free base	5-HT_1A Receptor, IC₅₀: 2.3 nM
Frovatriptan succinate hydrate	5-HT_1B Receptor, pEC₅₀: 8.2								≥99.0%
Almotriptan	5-HT_1B Receptor 5-HT_1D Receptor
SB228357		5-HT_2A Receptor, pKi: 6.9 5-HT_2C Receptor, pKi: 9 5-HT_2B Receptor, pKi: 8							≥99.0%
PU02			5-HT_3A Receptor, IC₅₀: 0.36 μM 5-HT ₃ AB, IC₅₀: 0.73 μM						≥99.0%
Alniditan dihydrochloride	human 5-HT_1B Receptor, IC₅₀: 1.7 nM human 5-HT_1D Receptor, IC₅₀: 1.3 nM 5-HT_1B Receptor, Kd: 0.9 nM 5-HT_1D Receptor, Kd: 1.2 nM
Deramciclane		5-HT_2A Receptor 5-HT_2C Receptor							98.13%
Velusetrag hydrochloride								5-HT₄ Receptor, pKi: 7.7	96.65%
Facinicline hydrochloride			5-HT₃ Receptor, Ki: 1.2 nM						99.93%
GR 113808	5-HT_1A Receptor	5-HT_2A Receptor 5-HT_2C Receptor	5-HT₃ Receptor					5-HT₄ Receptor	≥98.0%
Relenopride hydrochloride		5-HT_2A Receptor, Ki: 600 nM 5-HT_2B Receptor, Ki: 31 nM 5-HT_2B Receptor, IC₅₀: 2.1 μM						5-HT₄ Receptor, Ki: 4.96 nM	99.13%
Ipsapirone	5-HT_1A Receptor								99.37%
SB 204741		human 5-HT_2B Receptor, pKi: 7.1							99.91%
LY 344864 racemate	5-HT_1F Receptor								98.88%
Granisetron			5-HT₃ Receptor, IC₅₀: 17 μM
Risperidone hydrochloride		5-HT₂ Receptor, Ki: 4.8 nM
Dolasetron Mesylate hydrate			5-HT₃ Receptor						≥99.0%
Alosetron			5-HT₃ Receptor
Setiptiline		5-HT_2A Receptor 5-HT_2C Receptor	5-HT₃ Receptor						96.54%
Mosapride								5-HT₄ Receptor
Naftidrofuryl oxalate		5-HT₂ Receptor							95.81%
Eltoprazine	5-HT_1A Receptor 5-HT_1B Receptor	5-HT_2C Receptor							≥95.0%
Pimethixene	5-HT_1A Receptor, pKi: 7.63	5-HT_2A Receptor, pKi: 10.22 5-HT_2B Receptor, pKi: 10.44 5-HT_2C Receptor, pKi: 8.42
Ziprasidone hydrochloride	Rat 5-HT_1A Receptor, Ki: 3.4 nM human 5-HT_1A Receptor, Ki: 2.5 nM	Rat 5-HT_2A, Ki: 0.42 nM
Palonosetron			5-HT₃ Receptor
5-HT6/7 antagonist 1		5-HT_2A Receptor			5-HT₆ Receptor	5-HT₇ Receptor
Revexepride								5-HT₄ Receptor	95.81%
Lintopride			5-HT₃ Receptor					5-HT₄ Receptor	96.38%
Naratriptan	5-HT₁ Receptor
Lesopitron dihydrochloride	5-HT_1A Receptor, IC₅₀: 125 nM (in rat hippocampal membranes)								96.67%
(±)-Fabesetron hydrochloride			5-HT₃ Receptor					5-HT₄ Receptor
Naluzotan	5-HT_1A Receptor, IC₅₀: 20 nM 5-HT_1A Receptor, Ki: 5.1 nM								97.31%
F-15599	5-HT_1A Receptor, Ki: 3.4 nM								99.61%
Urapidil hydrochloride	5-HT_1A Receptor								≥99.0%
WAY-100635	5-HT_1A Receptor, pIC₅₀: 8.87 5-HT_1A Receptor, pA2: 9.71
SB-269970						Human 5-HT₇ Receptor , pKi: 8.3
Rodatristat							serotonin
AM9405			5-HT₃ Receptor, IC₅₀: 0.076 nM
NLX-204	5-HT_1A Receptor, pKi: 10.19
Rodatristat ethyl	5-HT₁ Receptor
SCH 39166 hydrobromide							5-HT Receptor, Ki: 80 nM
SEP-363856	5-HT_1A Receptor, EC₅₀: 2.3 μM 5-HT_1B Receptor, EC₅₀: 15.6 μM 5-HT_1D Receptor, EC₅₀: 0.262 μM	5-HT_2A Receptor, EC₅₀: >10 μM 5-HT_2C Receptor, EC₅₀: 30 μM				5-HT₇ Receptor, EC₅₀: 6.7 μM
RU 24969 hemisuccinate	5-HT_1A Receptor, Ki: 2.5 nM 5-HT_1B Receptor, Ki: 0.38 nM
Cariprazine D6	5-HT_1A Receptor, Ki: 2.6 nM
Befiradol	5-HT_1A Receptor
LY320135		5-HT₂ Receptor, Ki: 6.4 μM
BIMU 8								5-HT₄ Receptor, EC₅₀: 18 nM
U92016A hydrochloride	5-HT_1A Receptor, Ki: 0.2 nM
WAY 163909		5-HT_2C Receptor, Ki: 10.5±1.1 nM
PRX933 hydrochloride		5-HT_2C Receptor
4F 4PP oxalate		5-HT_2A Receptor, Ki: 5.3 nM 5-HT_2C Receptor, Ki: 620 nM							98.08%
Blonanserin D5		5-HT₂ Receptor
WAY-100135 dihydrochloride	5-HT_1A Receptor, IC₅₀: 34 nM
Mirtazapine D3		5-HT₂ Receptor	5-HT₃ Receptor
NPS ALX Compound 4a					5-HT₆ Receptor, IC₅₀: 7.2 nM 5-HT₆ Receptor, Ki: 0.2 nM				≥99.0%
AS19	5-HT_1A Receptor, Ki: 89.7 nM 5-HT_1B Receptor, Ki: 490 nM 5-HT_1D Receptor, Ki: 6.6 nM			5-HT₅ Receptor, Ki: 98.5 nM		Human 5-HT₇ Receptor , IC₅₀: 0.83 nM Human 5-HT₇ Receptor , Ki: 0.6 nM			≥99.0%
PNU-142633	5-HT_1D Receptor, Ki: 6 nM								≥98.0%
SB-215505		5-HT_2B Receptor, pKi: 8.3 5-HT_2A Receptor, pKi: 6.77 5-HT_2C Receptor, pKi: 7.66
PNU-96415E		5-HT_2A Receptor
3-Hydroxy agomelatine		5-HT_2C Receptor, IC₅₀: 3.2 μM 5-HT_2C Receptor, Ki: 1.8 μM
Isopteropodine		5-HT₂ Receptor
SB 258719 hydrochloride						5-HT₇ Receptor, pKi: 7.5
Masupirdine mesylate					5-HT₆ Receptor, Ki: 2.04 nM
Brexpiprazole S-oxide D8	5-HT_1A Receptor, Ki: 0.12 nM	5-HT_2A Receptor, Ki: 0.47 nM
2-Methyl-5-HT hydrochloride			5-HT₃ Receptor
PCPA methyl ester hydrochloride							serotonin		99.67%
Felcisetrag								huamn 5-HT_4(c) Receptor, pKi: 9.4	99.65%
PRX-07034 hydrochloride	5-HT_1A Receptor, Ki: 420 nM 5-HT_1B Receptor, Ki: 260 nM 5-HT_1D Receptor, Ki: 2.8 μM	5-HT_2A Receptor, IC₅₀: 2.5 μM 5-HT_2B Receptor, IC₅₀: 2.5 μM 5-HT_2C Receptor, IC₅₀: 3.7 μM			5-HT₆ Receptor, Ki: 4-8 nM 5-HT₆ Receptor, IC₅₀: 19 nM				98.09%
BRL-15572 hydrochloride	5-HT_1D Receptor
SB-221284		5-HT_2A Receptor, pKi: 6.4 5-HT_2B Receptor, pKi: 7.9 5-HT_2C Receptor, pKi: 8.6
Isamoltane hemifumarate	5-HT_1B Receptor, IC₅₀: 39 nM
Blonanserin D8		5-HT₂ Receptor
SCH-23390 maleate		5-HT_2C Receptor, Ki: 9.3 nM
8-Hydroxy-DPAT hydrobromide	5-HT_1A Receptor, pIC₅₀: 8.19
7-Desmethyl-3-hydroxyagomelatine		5-HT_2C Receptor
Perospirone hydrochloride	5-HT_1A Receptor, Ki: 2.9 nM 5-HT₁ Receptor, Ki: 18 nM	5-HT_2A Receptor, Ki: 0.6 nM
Indophagolin					5-HT₆ Receptor, IC₅₀: 1.0 μM				98.05%
Asimilobine							serotonergic receptor
Bifeprunox	5-HT_1A Receptor, pKi: 7.19 (cortex) 5-HT_1A Receptor, pEC₅₀: 6.37 (hippocampus)
Eplivanserin		5-HT_2A Receptor, IC₅₀: 5.8 nM (in rat cortical membrane) 5-HT_2A Receptor, Ki: 1.14 nM 5-HT_2C Receptor, IC₅₀: 120 nM
Ro 04-6790					Rat 5-HT₆ Receptor, pKi: 7.26 Human 5-HT₆ Receptor, pKi: 7.35
3-Hydroxy agomelatine D3		5-HT_2C Receptor, IC₅₀: 3.2 μM 5-HT_2C Receptor, Ki: 1.8 μM
ST1936 oxalate		5-HT_2B Receptor, Ki: 245 nM			5-HT₆ Receptor, Ki: 13 nM	Human 5-HT₇ Receptor , Ki: 168 nM
(R)-Mirtazapine D3			5-HT₃ Receptor
Eplivanserin (mixture)		5-HT_2A Receptor							99.95%
Org-12962		5-HT_2C Receptor, pEC₅₀: 7.01 5-HT_2A Receptor, pEC₅₀: 6.38 5-HT_2B Receptor, pEC₅₀: 6.28							≥98.0%
Repinotan	5-HT_1A Receptor, Ki: 0.19 nM (In calf hippocampus) 5-HT_1A Receptor, Ki: 0.25 nM (In rat and human cortex) 5-HT_1A Receptor, Ki: 0.59 nM (In rat hippocampus)					5-HT₇ Receptor, Ki: 6 nM
Desmethyl cariprazine	5-HT_1A Receptor, Ki: 2.6 nM
(R)-Mirtazapine			5-HT₃ Receptor
AR-A 2	5-HT_1A Receptor, Ki: 3070 nM 5-HT_1B/D Receptor, Ki: 20 nM	5-HT_2A Receptor, Ki: 339 nM
A-582941 dihydrochloride			5-HT₃ Receptor, Ki: 150 nM
Mesembrine							serotonin, Ki: 1.4 nM
(Rac)-WAY-161503		5-HT_2C Receptor, Ki: 4 nM 5-HT_2C Receptor, EC₅₀: 12 nM							≥99.0%
CART(62-76)(human,rat)							serotonin
DR4485 hydrochloride						5-HT₇ Receptor, pKi: 8.14
EMDT oxalate					5-HT₆ Receptor
LY266097 hydrochloride		5-HT_2B Receptor, pKi: 9.8 5-HT_2A Receptor, pKi: 7.7 5-HT_2C Receptor, pKi: 7.6
Urapidil D6	5-HT_1A Receptor
TIK-301		5-HT_2C Receptor 5-HT_2B Receptor
AP521	5-HT_1A Receptor, IC₅₀: 94 nM (in human) 5-HT_1A Receptor, IC₅₀: 135 nM (in rat) 5-HT_1B Receptor, IC₅₀: 254 nM (in rat) 5-HT_1B Receptor, IC₅₀: 5530 nM (in human) 5-HT_1D Receptor, IC₅₀: 418 nM (in human)			5-HT_5A Receptor, IC₅₀: 422 nM (in human)		5-HT₇ Receptor, IC₅₀: 198 nM (in rat)
Dehydroaripiprazole	5-HT_1A Receptor, Ki: 4.2 nM
Opiranserin		5-HT_2A Receptor, IC₅₀: 1.3 μM
(S)-Amisulpride						5-HT₇ Receptor, Ki: 900 nM			99.75%
BGC20-761		Human 5-HT_2A Receptor, Ki: 69 nM			Human 5-HT₆ Receptor, Ki: 20 nM
Didesmethyl cariprazine	5-HT_1A Receptor
5-HT7 agonist 1						5-HT₇ Receptor
Brilaroxazine	5-HT_1A Receptor, Ki: 1.5 nM	5-HT_2A Receptor, Ki: 2.5 nM 5-HT_2B Receptor, Ki: 0.19 nM				5-HT₇ Receptor, Ki: 2.7 nM
RS-127445		5-HT_2B Receptor, pKi: 9.5 nM
CART(62-76)(human,rat) TFA							serotonin
Aripiprazole (D8)		5-HT_2A Receptor 5-HT_2C Receptor
YM348		5-HT_2A Receptor, Ki: 13 nM 5-HT_2B Receptor, Ki: 2.5 nM 5-HT_2C Receptor, Ki: 0.89 nM 5-HT_2A Receptor, EC₅₀: 93 nM 5-HT_2B Receptor, EC₅₀: 3.2 nM 5-HT_2C Receptor, EC₅₀: 1 nM
NAS181	Rat 5-HT_1B Receptor, IC₅₀: 47 nM
BMY-14802 hydrochloride	5-HT_1A Receptor
SGS518 oxalate					5-HT₆ Receptor
Org-12962 hydrochloride		5-HT_2C Receptor, pEC₅₀: 7.01 5-HT_2A Receptor, pEC₅₀: 6.38 5-HT_2B Receptor, pEC₅₀: 6.28
(R)-Praziquantel D11		5-HT_2B Receptor
UNC9994	5-HT_1F Receptor, Ki: 26 nM	5-HT_2A Receptor, Ki: 140 nM 5-HT_2B Receptor, Ki: 25 nM 5-HT_2C Receptor, Ki: 512 nM
Sarizotan	5-HT_1D Receptor, IC₅₀: 500 nM (calf) 5-HT_1A Receptor, IC₅₀: 6.5 nM (rat) 5-HT_1A Receptor, IC₅₀: 0.1 nM (human) 5-HT_1B Receptor, IC₅₀: 600 nM (rat)	5-HT_2A Receptor, IC₅₀: 960 nM (rat, agonist site) 5-HT_2A Receptor, IC₅₀: 587 nM (human, antagonist site) 5-HT_2C Receptor, IC₅₀: 800 nM (pig) 5-HT_2B Receptor, IC₅₀: 108 nM (human)	5-HT₃ Receptor, IC₅₀: 3500 nM (NG 108 cells)	5-HT_5A Receptor, IC₅₀: 313 nM (human)	5-HT₆ Receptor, IC₅₀: 3300 nM (human)	5-HT₇ Receptor, IC₅₀: 10 nM (human)
ML 10302 hydrochloride			5-HT₃ Receptor, Ki: 782 nM					5-HT₄ Receptor, EC₅₀: 4 nM 5-HT₄ Receptor, Ki: 1.07 nM
NPS ALX Compound 4a dihydrochloride					5-HT₆ Receptor, IC₅₀: 7.2 nM 5-HT₆ Receptor, Ki: 0.2 nM
Frovatriptan succinate	5-HT_1B Receptor, pEC₅₀: 8.2
(S)-Mirtazapine		5-HT₂ Receptor	5-HT₃ Receptor
SB-200646		5-HT_2B Receptor, pKi: 7.5 5-HT_2C Receptor, pKi: 6.9 5-HT_2A Receptor, pKi: 5.2
5-HT4 antagonist 1								5-HT₄ Receptor, pKi: 9.6
cis-(Z)-Flupentixol dihydrochloride		5-HT_2A Receptor, Ki: 7 nM
Brexpiprazole S-oxide	5-HT_1A Receptor, Ki: 0.12 nM	5-HT_2A Receptor, Ki: 0.47 nM
Masupirdine free base					5-HT₆ Receptor, Ki: 2.04 nM
Valerenic acid				5-HT_5A Receptor, IC₅₀: 17.2 μM
Harmine hydrochloride		5-HT_2A Receptor, Ki: 397 nM
Renzapride								5-HT₄ Receptor, Ki: 115 nM
2-Methyl-5-HT maleate			5-HT₃ Receptor
Risperidone mesylate		5-HT_2A Receptor, Ki: 4.8 nM
Iloperidone hydrochloride	Rat 5-HT_1A Receptor, Ki: 168 nM	Rat 5-HT₂ Receptor, Ki: 3.1 nM Human 5-HT_2A Receptor, Ki: 5.6 nM Human 5-HT_2C Receptor, Ki: 42.8 nM			Rat 5-HT₆ Receptor, Ki: 42.7 nM	Rat 5-HT₇ Receptor, Ki: 21.6 nM
Agomelatine (L(+)-Tartaric acid)		5-HT_2C Receptor, pKi: 6.4 (native porcine) 5-HT_2C Receptor, pKi: 6.2 (human)							99.82%
Alosetron ((Z)-2-butenedioate)			5-HT₃ Receptor
Pardoprunox	5-HT_1A Receptor, pEC₅₀: 6.3
Dolasetron Mesylate			5-HT₃ Receptor
Alosetron (Hydrochloride(1:X))			5-HT₃ Receptor
Idalopirdine					5-HT₆ Receptor, Ki: 0.83 nM
Pizotifen malate		5-HT_2A Receptor
Piboserod hydrochloride								5-HT₄ Receptor
Nexopamil racemate		5-HT₂ Receptor
Abaperidone		5-HT_2A Receptor, IC₅₀: 6.2 nM
Irindalone		5-HT₂ Receptor
Pancopride			5-HT₃ Receptor
Sulamserod								5-HT₄ Receptor
Alniditan	human 5-HT_1B Receptor, IC₅₀: 1.7 nM (in HEK 293 cell) human 5-HT_1D Receptor, IC₅₀: 1.3 nM (in HEK 293 cell) 5-HT_1B Receptor, Kd: 0.9 nM 5-HT_1D Receptor, Kd: 1.2 nM
RG-12915			5-HT₃ Receptor, IC₅₀: 0.16 nM
NEO 376	5-HT₁ Receptor
MHP 133								5-HT₄ Receptor
Wf-516	5-HT_1A Receptor, Ki: 5 nM	5-HT_2A Receptor, Ki: 40 nM
T 82			5-HT₃ Receptor
Ondansetron hydrochloride			5-HT₃ Receptor
CP-809101		5-HT_2C Receptor, pEC₅₀: 9.96 5-HT_2B Receptor, pEC₅₀: 7.19 5-HT_2A Receptor, pEC₅₀: 6.81
Zatosetron maleate			5-HT₃ Receptor
(4E)-SUN9221		5-HT₂ Receptor
5-HT3 antagonist 1			5-HT₃ Receptor
5-HT3 antagonist 3			5-HT₃ Receptor, Ki: 0.25 nM
5-HT3-In-1			5-HT₃ Receptor
5-HT2 antagonist 1		5-HT₂ Receptor
5-HT3 antagonist 2			5-HT₃ Receptor
5-HT2A antagonist 1		5-HT_2A Receptor
5HT6-ligand-1					5-HT₆ Receptor, Ki: 1.43 nM

Name
Email *

	Sorry, but the email address you supplied was invalid.